These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

848 related articles for article (PubMed ID: 31815633)

  • 1. Tumorigenesis, diagnosis, and therapeutic potential of exosomes in liver cancer.
    Wang H; Lu Z; Zhao X
    J Hematol Oncol; 2019 Dec; 12(1):133. PubMed ID: 31815633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomes in hepatocellular carcinoma microenvironment and their potential clinical application value.
    He R; Wang Z; Shi W; Yu L; Xia H; Huang Z; Liu S; Zhao X; Xu Y; Yam JWP; Cui Y
    Biomed Pharmacother; 2021 Jun; 138():111529. PubMed ID: 34311529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of extracellular vesicles in mediating progression, metastasis and potential treatment of hepatocellular carcinoma.
    Yang N; Li S; Li G; Zhang S; Tang X; Ni S; Jian X; Xu C; Zhu J; Lu M
    Oncotarget; 2017 Jan; 8(2):3683-3695. PubMed ID: 27713136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosome-mediated secretion of LOXL4 promotes hepatocellular carcinoma cell invasion and metastasis.
    Li R; Wang Y; Zhang X; Feng M; Ma J; Li J; Yang X; Fang F; Xia Q; Zhang Z; Shang M; Jiang S
    Mol Cancer; 2019 Jan; 18(1):18. PubMed ID: 30704479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HCC-derived exosomes elicit HCC progression and recurrence by epithelial-mesenchymal transition through MAPK/ERK signalling pathway.
    Chen L; Guo P; He Y; Chen Z; Chen L; Luo Y; Qi L; Liu Y; Wu Q; Cui Y; Fang F; Zhang X; Song T; Guo H
    Cell Death Dis; 2018 May; 9(5):513. PubMed ID: 29725020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-125a/b inhibits tumor-associated macrophages mediated in cancer stem cells of hepatocellular carcinoma by targeting CD90.
    Wang Y; Wang B; Xiao S; Li Y; Chen Q
    J Cell Biochem; 2019 Mar; 120(3):3046-3055. PubMed ID: 30536969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of exosomes in the development and treatment of hepatocellular carcinoma.
    Li X; Li C; Zhang L; Wu M; Cao K; Jiang F; Chen D; Li N; Li W
    Mol Cancer; 2020 Jan; 19(1):1. PubMed ID: 31901224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of exosomes and exosomal microRNAs in hepatocellular carcinoma: Potential in diagnosis and antitumour treatments (Review).
    Pan JH; Zhou H; Zhao XX; Ding H; Li W; Qin L; Pan YL
    Int J Mol Med; 2018 Apr; 41(4):1809-1816. PubMed ID: 29328436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosome plays an important role in the development of hepatocellular carcinoma.
    Li LM; Liu ZX; Cheng QY
    Pathol Res Pract; 2019 Aug; 215(8):152468. PubMed ID: 31171380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hepatocellular carcinoma-derived exosomal miRNA expression and its clinical value].
    Wu MN; Sun JY; Yao M; Yao DF
    Zhonghua Gan Zang Bing Za Zhi; 2020 Jan; 28(1):83-86. PubMed ID: 32023707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological functions and clinical applications of exosomal non-coding RNAs in hepatocellular carcinoma.
    Li C; Xu X
    Cell Mol Life Sci; 2019 Nov; 76(21):4203-4219. PubMed ID: 31300868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The functional role of exosome in hepatocellular carcinoma.
    Liu H; Li B
    J Cancer Res Clin Oncol; 2018 Nov; 144(11):2085-2095. PubMed ID: 30062486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomes derived from HCC cells induce sorafenib resistance in hepatocellular carcinoma both in vivo and in vitro.
    Qu Z; Wu J; Wu J; Luo D; Jiang C; Ding Y
    J Exp Clin Cancer Res; 2016 Sep; 35(1):159. PubMed ID: 27716356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Function and biomedical implications of exosomal microRNAs delivered by parenchymal and nonparenchymal cells in hepatocellular carcinoma.
    Wang HC; Yin WX; Jiang M; Han JY; Kuai XW; Sun R; Sun YF; Ji JL
    World J Gastroenterol; 2023 Oct; 29(39):5435-5451. PubMed ID: 37900996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting therapy for hepatocellular carcinoma by delivering microRNAs as exosomal cargo.
    Suda T
    World J Gastroenterol; 2024 May; 30(17):2369-2370. PubMed ID: 38813056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA highly up-regulated in liver cancer promotes exosome secretion.
    Cao SQ; Zheng H; Sun BC; Wang ZL; Liu T; Guo DH; Shen ZY
    World J Gastroenterol; 2019 Sep; 25(35):5283-5299. PubMed ID: 31558873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional Roles and Therapeutic Applications of Exosomes in Hepatocellular Carcinoma.
    Santangelo L; Battistelli C; Montaldo C; Citarella F; Strippoli R; Cicchini C
    Biomed Res Int; 2017; 2017():2931813. PubMed ID: 28265569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-199a-modified exosomes from adipose tissue-derived mesenchymal stem cells improve hepatocellular carcinoma chemosensitivity through mTOR pathway.
    Lou G; Chen L; Xia C; Wang W; Qi J; Li A; Zhao L; Chen Z; Zheng M; Liu Y
    J Exp Clin Cancer Res; 2020 Jan; 39(1):4. PubMed ID: 31898515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-related microRNAs and their role as tumor suppressors and oncogenes in hepatocellular carcinoma.
    Gailhouste L; Ochiya T
    Histol Histopathol; 2013 Apr; 28(4):437-51. PubMed ID: 23224781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Hippo pathway in hepatocellular carcinoma: Non-coding RNAs in action.
    Shi X; Zhu HR; Liu TT; Shen XZ; Zhu JM
    Cancer Lett; 2017 Aug; 400():175-182. PubMed ID: 28461246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.